5 天前 - … % - 71%) in preventing COVID-19-related hospitalizations. The study was conducted
during a period when the Beta (B.1.351) and Delta (B.1.617.2) SARS-CoV-2 variants were …

5 天前 - … her COVID-19 VidPrevtyn Beta monovalent B.1.351 vaccine (Sanofi). This marked
her sixth dose of a COVID-19 … A clinical diagnosis of GPP secondary to the COVID-19 booster …

6 天前 - … In the second chapter, the in vitro capacity of antibodies generated against the
SARSCoV-2 wild-type strain and B.1, B.1.1.7 and B.1.351 variants after vaccination of healthcare …

7 天前 - … COVID-19-related symptoms among those who tested positive or negative for the
beta variant of SARS-CoV-2 (B.1.351… for SARS-CoV-2. n = 925 individuals that were tested for …

41 天前 - … Tandem 6 immuno-depletion of CD4+ and CD8+ T cells in C57BL/6 mice
followed by infection with SARS- 7 CoV-2 variant of concern (VOC) beta B.1.351 resulted in …

42 天前 - … 541 NTD domain of the spike glycoprotein of the B.1.351 variant would lead to a
loss of … Nevertheless, in Morocco, the circulation of B.1.351 has not been as concerning as in …

48 天前 - … California, B.1.351 in South Africa, while B.1.617 and B.… investigate the correlations
between SARS-CoV-2 S-gene … , and history of previous COVID-19 disease, in patients that …

64 天前 - Wastewater surveillance has become a valuable tool to monitor the emergence of
SARS-CoV-2 variants of concern (VOCs) at community level. In this study, we aimed to …

72 天前 - … V2 or B.1.351 (Beta) lineage) developed independently of the B.1.1.7 lineage in
South … Delta variant blowouts are almost two times faster than the original SARSCoV-2 virus. …

84 天前 - … * or ncov* or covid* or sarscov* or sarscov* or Sars-… or ncov-19 or 2019-novel CoV
or severe acute respiratory syndrome coronavirus 2 or sars-cov2 or sars-cov-2 or sarscov2 or …